Rao Prabhala

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur et al. · Nature Communications · 2021 · 409 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

Mariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima et al. · Blood · 2009 · 398 citations · Full text

Medicine, Immunology, Oncology +10

Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

Rao Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti et al. · Blood · 2010 · 346 citations · Full text

Life Sciences, Immunology, Oncology +17

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

Masahisa Jinushi, Matthew W. Vanneman, Nikhil C. Munshi et al. · Proceedings of the National Academy of Sciences · 2008 · 251 citations · Full text

Life Sciences, Immunology, Pathology +17

Dysfunctional T regulatory cells in multiple myeloma

Rao Prabhala, Paola Neri, Jooeun Bae et al. · Blood · 2005 · 239 citations · Full text

Life Sciences, Hematology, Immunology +14